Rovin Capital Pfizer Inc Transaction History

Rovin Capital

$361 Million
Q3 2025

A detailed history of Rovin Capital transactions in Pfizer Inc stock. As of the latest transaction made, Rovin Capital holds 25,378 shares of PFE stock, worth $625,567. This represents 0.18% of its overall portfolio holdings.

Number of Shares

25,378

Previous 26,662 4.82%

Holding current value

$625,567

Previous $646,000 0.15%

% of portfolio

0.18%

Previous 0.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$23.29 - $25.88 $29,904 - $33,229	-1,284 Reduced 4.82%	25,378 $647,000
Q2 2025 Aug 06, 2025	SELL	$21.59 - $24.84 $39,833 - $45,829	-1,845 Reduced 6.47%	26,662 $646,000
Q1 2025 Apr 25, 2025	BUY	$25.01 - $27.13 $107,618 - $116,740	4,303 Added 17.78%	28,507 $722,000
Q4 2024 Jan 14, 2025	SELL	$24.8 - $30.19 $80,773 - $98,328	-3,257 Reduced 11.86%	24,204 $642,000
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $114,650 - $129,923	4,139 Added 17.75%	27,461 $795,000
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $92,249 - $108,099	3,652 Added 18.57%	23,322 $653,000
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $99,987 - $114,817	3,862 Added 24.43%	19,670 $546,000
Q4 2023 Mar 12, 2024	BUY	$26.13 - $33.94 $38,594 - $50,129	1,477 Added 10.31%	15,808 $455,000
Q3 2023 Oct 25, 2023	BUY	$32.09 - $37.51 $191,801 - $224,197	5,977 Added 71.55%	14,331 $475,000
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $301,746 - $349,113	8,354 New	8,354 $306,000
Q1 2022 Jun 13, 2022	SELL	$45.75 - $56.69 $465,918 - $577,330	-10,184 Closed	0 $0
Q4 2021 Feb 24, 2022	BUY	$41.32 - $61.25 $420,802 - $623,770	10,184 New	10,184 $601,000

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rovin Capital , based on Form 13F filings with the SEC.

News

Stay updated on Rovin Capital with notifications on news.

Account